Phase I doseâescalation trial to repurpose propagermanium, an oral CCL2 inhibitor, in patients with breast cancer
Masuda, Takaaki, Noda, Miwa, Kogawa, Takahiro, Kitagawa, Dai, Hayashi, Naoki, Jomori, Takahito, Nakanishi, Yoichi, Nakayama, Keiichi I., Ohno, Shinji, Mimori, KoshiJournal:
Cancer Science
DOI:
10.1111/cas.14306
Date:
February, 2020
File:
PDF, 736 KB
2020